Biology Reference
In-Depth Information
Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, Shearer GM. 1996. In-vitro restora-
tion of T cell immune function in human immunode®ciency virus-positive persons: e¨ects of
interleukin (IL12) and anti-IL10. J Infect Dis 173: 1085±1091.
Lane HC, Masur H, Gelmann EP, Longo DL, Steis RG, Chused T, Whalen G, Edgar LC, Fauci
AS. 1985. Correlation between immunologic function and clinical subpopulations of patients
with the acquired immune de®ciency syndrome. Am J Med 78: 417±422.
Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St. Clair M, Kotzin BL, Fox L,
Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, Kessler H. 1998. Im-
munologic responses associated with 12 weeks of combination antiretroviral therapy consisting
of zidovudine, lamivudine and ritonavir: results of AIDS clinical trials group protocol 315.
J Infect Dis 178: 70±79.
Lempicki RA, Kovacs JA, Baseler MW, Adelsberger JW, Dewar RL, Natarajan V, Bosche MC,
Metcalf JA, Stevens RA, Lambert LA, Alvord WG, Polis MA, Davey RT, Dimitrov DS, Lane
HC. 2000. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of
CD4
and CD8
T cell turnover in HIV-infected patients. Proc Natl Acad Sci USA 97: 13778±
13783.
Levitz SM. 1998. Improvement in CD4
cell counts despite persistently detectable HIV load. N
Engl J Med 338: 1074±1075.
Li TS, Tubiana R, Katlama C, Calvez V, Mohand HA, Autran B. 1998. Long lasting recovery in
CD4
T cell function mirrors viral load reduction after highly active anti-retroviral therapy in
patients with advanced HIV disease. Lancet 351: 1682±1686.
Li TS, Tubiana R, Fillet AM, Autran B, Katlama C. 1999. Negativation of cytomegalovirus blood
culture with restoration of CD4
T cell reactivity to CMV after HAART in an HIV-1 infected
patient. J Acquir Immune De®c Syndr Hum Retrovirol 20: 514±515.
Lisziewicz J, Rosenberg E, Lieberman J, Jessen H, Lopalco L, Siliciano R, Walker B, Lori F. 1999.
Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med 340: 1683±
1684.
Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. 1993. T-cell regeneration after bone
marrow transplantation: di¨erential CD45 isoform expression on thymic-derived versus thymic-
independent progeny. Blood 82: 2585±2894.
Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, et al. 1995. Age,
thymopoiesis, and CD4
T-lymphocyte regeneration after intensive chemotherapy. N Engl J
Med 332: 143±149.
Marandin A, Katz A, Oksenhendler E, Tulliez M, Picard F, Vainchenker W, Louache F. 1996.
Loss of primitive hematopoietic progenitors in patients with human immunode®ciency virus in-
fection. Blood 88: 4568±4578.
Matloubian M, Conception RJ, Ahmed R. 1994. CD4
T cells are required to sustain CD8
cyto-
toxic T cell responses during chronic viral infection. J Virol 68: 8056±8063.
McCune JM, Loftus R, Schmidt DK, Carrell P, Webster D, Swor-Yim LB, Francis IR, Gross BH,
Grant RM. 1998. High prevalence of thymic tissue in adults with human immunode®ciency
virus-1 infection. J Clin Invest 101: 2301±2308.
McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S,
Neese R, Hellerstein M. 2000. Factors in¯uencing T-cell turnover in HIV-1 seropositive pa-
tients. J Clin Invest 105: R1±R8.
McFarland EJ, Harding PA, MaWhinney S, Schooley RT, Kuritzkes DR. 1998. In-vitro e¨ects
of IL-12 on HIV-1 speci®c CTL lines from HIV-1 infected children. J Immunol 161: 513±
519.
Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori DS, Bernardi ML, Paganelli R,
Aiuti F. 1999. Long-term evaluation of T-cell subsets and T-cell function after HAART in ad-
vanced stage HIV-1 disease. AIDS 13: 1187±1193.
